KCNH5 Inhibitors

KCNH5 inhibitors are chemicals that specifically target the KCNH5 ion channel, a member of the voltage-gated potassium channel family, by either directly blocking the channel pore or affecting associated proteins to modulate ion flow. Astemizole and Dofetilide are two compounds that directly inhibit KCNH5 by blocking its ion channel, resulting in reduced potassium ion flow and thus affecting cellular excitability. Similarly, Quinidine and E-4031 also function by acting on the channel's pore to disrupt the ion flow. Chromanol 293B specifically targets KCNH5 by blocking the channel and changing the action, thereby affecting the cellular responses.

Imipramine, Terfenadine, and Amiodarone also block the KCNH5 channel but may have different binding sites or mechanisms of action. Clofilium acts in a similar manner by inhibiting the ion channel directly. Cisapride affects cellular excitability by modulating potassium ion transport through the blocking of KCNH5. Anandamide serves as an interesting case; it inhibits KCNH5 by interacting with channel proteins, demonstrating that channel-protein interactions can also serve as a point of intervention. These inhibitors span a broad spectrum of functionalities and can be classified into two general types: those that inhibit by direct interaction with the ion channel and those that act on associated proteins to inhibit KCNH5 indirectly.